Patent details

Basic Information

Publication number:

EP4013420

PCT Application Number:

US2020046060

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP207644964

PCT Publication Number:

WO2021030526

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME

French Title of Invention:

PROCÉDÉ DE BLOCAGE OU D'AMÉLIORATION DU SYNDROME DE LIBÉRATION DES CYTOKINES

German Title of Invention:

VERFAHREN ZUR BLOCKIERUNG ODER LINDERUNG DES ZYTOKINFREISETZUNGSSYNDROMS

SPC Number:

Dates

Filing date:

13/08/2020

Grant date:

01/11/2023

EP Publication Date:

22/06/2022

PCT Publication Date:

18/02/2021

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/11/2023

EP B1 Publication Date:

01/11/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/08/2024

Expiration date:

13/08/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/10/2023

 

 

Name:

Rigel Pharmaceuticals, Inc.

Address:

611 Gateway Boulevard Suite 900, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:

TAYLOR, Vanessa

Address:

United States (US)

2

Name:

YOUNG, Chi

Address:

United States (US)

3

Name:

ISSAKANI, Sarkiz

Address:

United States (US)

Priority

Priority Number:

201962886806 P

Priority Date:

14/08/2019

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/5383; A61K 31/7064; A61P 43/00;

Publication

European Patent Bulletin

Issue number:

202344

Publication date:

01/11/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages